{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:36:51Z","timestamp":1782297411208,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jviromet.2020.113966","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T18:17:28Z","timestamp":1599416248000},"page":"113966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats"],"prefix":"10.1016","volume":"286","author":[{"given":"Diego","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Etcheverrigaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Kratje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2020.113966_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-017-0969-z","article-title":"Vaccine adjuvants: smart components to boost the immune system","author":"Bastola","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jviromet.2020.113966_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.12768","article-title":"Development and assessment of a new cage-like particle adjuvant","author":"Bertona","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jviromet.2020.113966_bib0015","first-page":"4","article-title":"Vampire Bat-transmitted rabies in cattle","volume":"10","author":"Carlos","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jviromet.2020.113966_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clim.2017.08.004","article-title":"Adjuvant formulations for virus-like particle (VLP) based vaccines","volume":"183","author":"Cimica","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jviromet.2020.113966_bib0025","first-page":"8463","article-title":"A Third-Generation Lentivirus Vector with a Conditional Packaging System","volume":"72","author":"Dull","year":"1998","journal-title":"Society"},{"key":"10.1016\/j.jviromet.2020.113966_bib0030","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","author":"Ertl","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jviromet.2020.113966_bib0035","first-page":"1","article-title":"The Road to Dog Rabies Control and Elimination\u2014What Keeps Us from Moving Faster?","volume":"5","author":"Fahrion","year":"2017","journal-title":"Front. Public Heal."},{"key":"10.1016\/j.jviromet.2020.113966_bib0040","first-page":"204","article-title":"Optimization of the production process for a vlp-based rabies vaccine","volume":"12","author":"Fontana","year":"2018","journal-title":"BMC Proc."},{"key":"10.1016\/j.jviromet.2020.113966_bib0045","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.vaccine.2015.03.088","article-title":"Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate","volume":"33","author":"Fontana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2020.113966_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.02.031","article-title":"Rabies virus-like particles expressed in HEK293 cells","author":"Fontana","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2020.113966_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cimid.2019.04.009","article-title":"A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications","volume":"65","author":"Fontana","year":"2019","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jviromet.2020.113966_bib0060","article-title":"New human rabies vaccines in the pipeline","author":"Fooks","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.jviromet.2020.113966_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pervac.2011.05.004","article-title":"Vaccine adjuvants","volume":"1","author":"Gar\u00e7on","year":"2011","journal-title":"Perspect. Vaccinol."},{"key":"10.1016\/j.jviromet.2020.113966_bib0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.jviromet.2020.113966_bib0075","first-page":"1","article-title":"Estimating the Global Burden of Endemic Canine Rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jviromet.2020.113966_bib0080","article-title":"Recovery from rabies: A call to arms","volume":"10\u201312","author":"Jackson","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jviromet.2020.113966_bib0085","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/v6051911","article-title":"Vampire bat rabies: Ecology, epidemiology and control","volume":"6","author":"Johnson","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2020.113966_bib0090","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.vaccine.2017.02.014","article-title":"Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings","volume":"35","author":"Lavan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2020.113966_bib0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.11.25","article-title":"ISCOM technology-based Matrix MTM adjuvant: success in future vaccines relies on formulation","volume":"10","author":"L\u00f6vgren Bengtsson","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jviromet.2020.113966_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.antiviral.2013.03.011","article-title":"Eliminating canine rabies, the principal source of human infection: What will it take?","volume":"98","author":"Meslin","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2020.113966_bib0105","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-Specific Antibodies : Measuring Surrogates of Protection against a Fatal Disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jviromet.2020.113966_bib0110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.addr.2004.02.004","article-title":"Current status and potential application of ISCOMs in veterinary medicine","volume":"56","author":"Morein","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jviromet.2020.113966_bib0115","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1186\/1753-6561-5-S8-P7","article-title":"A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis","volume":"5","author":"Prieto","year":"2011","journal-title":"BMC Proc."},{"key":"10.1016\/j.jviromet.2020.113966_bib0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/erv.11.37","article-title":"Virus-like particles: innate immune stimulators","volume":"10","author":"Raghunandan","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jviromet.2020.113966_bib0125","first-page":"314","article-title":"Cell-culture vaccines for veterinary use","author":"Reculard","year":"1996","journal-title":"Lab. Tech. rabies"},{"key":"10.1016\/j.jviromet.2020.113966_bib0130","first-page":"1","article-title":"Potential economic benefits of eliminating canine rabies","author":"Shwiff","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2020.113966_bib0135","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.vaccine.2009.05.032","article-title":"ISCOMs and ISCOMATRIX","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2020.113966_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2017.00009","article-title":"Elimination of Dog-mediated human rabies deaths by 2030: Needs assessmnet and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.jviromet.2020.113966_bib0145","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996","journal-title":"Lab. Tech. rabies"},{"key":"10.1016\/j.jviromet.2020.113966_bib0150","first-page":"6","article-title":"Rabies: Still a silent killer targeting the poor","author":"Wilde","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2020.113966_bib0155","series-title":"WHO Expert Consultation on rabies","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jviromet.2020.113966_bib0160","first-page":"309","article-title":"Rabies vaccines: WHO position paper","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.jviromet.2020.113966_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1743-422X-9-50","article-title":"Rabies molecular virology, diagnosis, prevention and treatment","volume":"9","author":"Yousaf","year":"2012","journal-title":"Virol. J."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093420302184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093420302184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:52:39Z","timestamp":1759056759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093420302184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S0166093420302184"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2020.113966","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2020.113966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113966"}}